Hutchison Chi-Med begins fruquintinib trial in US

12:06 EST 15 Dec 2017 | FinanzNachrichten

Hutchison China MediTech, known as Chi-Med, has initiated the United States Phase I bridging clinical trial of fruquintinib, it announced on Friday. The AIM-traded firm said fruquintinib was a "hig...

Original Article: Hutchison Chi-Med begins fruquintinib trial in US


More From BioPortfolio on "Hutchison Chi-Med begins fruquintinib trial in US"

Quick Search


Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...